Table 5 Mortality.
From: Stem cell-based therapy for COVID-19 and ARDS: a systematic review
Mortality MSC (death/n) | Mortality in control (death/n) | Reason of death | Articles |
|---|---|---|---|
4/31 | NA | Complications of COVID-19 | |
1/1 | NA | Septic shock after empyema | |
1/12 | 7/12 | MSC: acute respiratory failure Placebo: multiple organ failure (6) and respiratory failure (1) | |
2/5 | NA | Acute renal failure Cardiomyopathy and liver failure Bacterial pneumonia Complications of COVID-19 | |
0/12 | 3/29 | Complications of COVID-19 | |
2/16 | NA | Bacterial pneumonia and septic shock Complications of COVID-19 | |
2/9 | NA | Multiple organ failure Respiratory arrest | |
15/40 | 5/20 | MSC: cardiopulmonary arrest (1) Multiple organ failure Not specified | |
1/5 | 10/18 | MSC: multiple organ failure Placebo: acute liver dysfunction (4); multiorgan failure (3); palliative care (2); cerebral bleeding (1) | |
4/24 | NA | Complications of COVID-19 | |
1/1 | NA | Multiple organ failure | |
1/6 | 2/6 | MSC: multiple organ failure Placebo: multiple organ failure and sepsis | |
2/13 | NA | Massive gastrointestinal bleeding due to a gastric ulcer Secondary fungal pneumonia | |
5/20 | 4/10 | Not specified | |
0/7 | 1/3 | Not specified | |
5/11 | NA | Multiple organ failure Cardiac arrest | |
1/1 | NA | Lung transplant rejection |
